Blue Bell Private Wealth Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Blue Bell Private Wealth Management's VCYT Position: Q2 2026 in Review
Blue Bell Private Wealth Management sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 85 shares — an estimated $2.74K sold.
Blue Bell Private Wealth Management first reported a position in VCYT in Q4 2021 and held it in 18 quarters. The position peaked at $3.58K in Q4 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Blue Bell Private Wealth Management reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
- Blue Bell Private Wealth Management sold 85 Veracyte shares in Q2 2026, an estimated $2.74K.
- Blue Bell Private Wealth Management first reported a position in Veracyte in Q4 2021 and held it in 18 quarters.
- Blue Bell Private Wealth Management's Veracyte position peaked at $3.58K in Q4 2025.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Blue Bell Private Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.